Why did this happen?
Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading.
For more information you can review our Terms of Service and Cookie Policy.
1 час назад @ bloomberg.comDeveloper tools, one menu click away. Discussion | Link
1 day, 5 hours назад @ producthunt.comAgentic Browser with Claude Code UX Discussion | Link
1 day, 14 hours назад @ producthunt.com
UK AgriBioTech startup Resurrect Bio closes €8.8 million Series A to develop disease-resistant crops
Resurrect Bio, a London-based agricultural BioTech startup developing disease-resistant crops, has closed its oversubscribed Series A funding round at €8.8 million ($10.3 million).
In February 2026, the company made an initial close of over €6.8 million ($8 million) in its Series A round.
Dr Cian Duggan, CEO of Resurrect Bio.
Resurrect Bio provides the seed industry with a sustainable alternative to chemical crop protection by resurrecting complex resistance mechanisms.
In March 2026, the company announced its partnership with Corteva Agriscience to develop disease resistance in corn.
2 days, 8 hours назад @ eu-startups.com